TrialAssure debuts clinical data anonymization software

By Maggie Lynch contact

- Last updated on GMT

(Image: Getty/Peter Howell)
(Image: Getty/Peter Howell)

Related tags: TrialAssure, Clinical data, SaaS, Clinical trial, Clinical trial data, Patient centricity, Big data

TrialAssure releases anonymizing SaaS to enable sponsors to share clinical trial data, as the industry shifts towards utilizing big data while maintaining patient privacy.

The limited release of TrialAssure’s latest software-as-a-service (SaaS) application, Anonymize, will allow sponsors to anonymize clinical trial data automatically, to ease challenges that may arise when sharing data while still maintaining patient privacy.

TrialAssure stated that the SaaS will anonymize this data using industry-standard techniques that can be reused and customized for each dataset. It also has the capability to assign a risk score associated with the re-identification of transformed data, based upon thresholds set by the sponsor.

“The pharmaceutical industry is moving towards sharing data more openly. Health authorities and scientific journal editors alike may require greater levels of data transparency in the not-so-distant future,”​ Mohamad Zahreddine, CIO of TrialAssure, said in a statement.

End users can build a library of custom and reusable variables to reapply the same anonymization rules across studies, in which over time, a library develops to make the total process more efficient.

“In the age of big data, research organizations can leverage pre-existing, anonymized data to speed-up the development process for life-changing medicines,”​ Zahreddine continued.

Anonymize will join the ranks of TrialAssure’s suite of transparency tools ​that allow for the sharing of information across health authorities without compromising patient privacy.

TrialAssure was unable to respond to our request for comment

Related news

Show more

Related products

show more

Stability Testing As a Quality Control Measure

Stability Testing As a Quality Control Measure

Frontage Laboratories | 19-Jun-2019 | Technical / White Paper

Stability testing is, in essence, a quality control process and is there¬fore a vital component of every phase of clinical development for both large and...

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 05-Nov-2018 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

Baxter’s Oncology Contract Manufacturing

Baxter’s Oncology Contract Manufacturing

Baxter BioPharma Solutions | 29-Aug-2018 | Product Brochure

Baxter BioPharma Solutions’ FOYA award-winning facility in Halle/Westfalen, Germany, offers state-of-the-art parenteral cGMP manufacturing at one location,...

Related suppliers

Follow us

Products

View more

Webinars